Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003
Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003
Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
Anabolic effects and safety assessments of TH9507, a growth hormone releasing factor (GRF) analog, in patients with COPD-associated wasting Source: Eur Respir J 2004; 24: Suppl. 48, 292s Year: 2004
Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 573s Year: 2003
The relationship between thyroid hormones, somatomedin-C (IGF-1), anabolic hormones and the severity of disease in chronic obstructive lung disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006
Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats Source: Eur Respir J 2011; 38: 870-877 Year: 2011
Plasma levels of estradiol, progesterone, FSH, LH, testosterone, DHEA, aldosterone and cortisol levels in active pulmonary tuberculosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001
Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats Source: Eur Respir J 2013; 41: 104-114 Year: 2013
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
Effects of insulin-like growth factor on nitrogen balance during hypoxic exposure Source: Eur Respir J 2002; 20: 293-299 Year: 2002
Effect of pulmonary rehabilitation on muscle inflammation and muscle insulin-like growth factor-I in COPD Source: Annual Congress 2006 - Physiological responses to rehabilitation Year: 2006
Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Circulating levels of IGF-I and IGFBP-3 in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
Roles of sex hormones on bone morphogenetic protein signaling in pulmonary artery differed between testosterone and estrogen Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Increased expression of insulin-like growth factor-binding protein-7 (IGFBP7) in fibroblasts from patients with emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004
Growth hormone-releasing hormone receptor antagonist MIA-602 modulates mouse lung inflammation and fibrosis due to bleomycin Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018 Year: 2018